Cutera Inc
Cutera, Inc. provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fracti… Read more
Cutera Inc (CUTR) - Net Assets
Latest net assets as of September 2024: $-252.87 Million USD
Based on the latest financial reports, Cutera Inc (CUTR) has net assets worth $-252.87 Million USD as of September 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($234.42 Million) and total liabilities ($487.29 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-252.87 Million |
| % of Total Assets | -107.87% |
| Annual Growth Rate | N/A |
| 5-Year Change | -474.02% |
| 10-Year Change | -313.43% |
| Growth Volatility | 171.37 |
Cutera Inc - Net Assets Trend (2000–2023)
This chart illustrates how Cutera Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Cutera Inc (2000–2023)
The table below shows the annual net assets of Cutera Inc from 2000 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | $-171.83 Million | -1031.88% |
| 2022-12-31 | $-15.18 Million | -126.84% |
| 2021-12-31 | $56.57 Million | -0.55% |
| 2020-12-31 | $56.88 Million | +23.81% |
| 2019-12-31 | $45.94 Million | -0.96% |
| 2018-12-31 | $46.39 Million | -28.52% |
| 2017-12-31 | $64.89 Million | +6.36% |
| 2016-12-31 | $61.01 Million | +21.94% |
| 2015-12-31 | $50.03 Million | -37.85% |
| 2014-12-31 | $80.51 Million | -4.46% |
| 2013-12-31 | $84.27 Million | -7.17% |
| 2012-12-31 | $90.77 Million | -0.87% |
| 2011-12-31 | $91.57 Million | -4.03% |
| 2010-12-31 | $95.42 Million | -5.39% |
| 2009-12-31 | $100.85 Million | -10.04% |
| 2008-12-31 | $112.11 Million | +2.52% |
| 2007-12-31 | $109.35 Million | -0.35% |
| 2006-12-31 | $109.73 Million | +12.92% |
| 2005-12-31 | $97.18 Million | +41.96% |
| 2004-12-31 | $68.46 Million | +769.28% |
| 2003-12-31 | $7.88 Million | +153.54% |
| 2002-12-31 | $3.11 Million | +153.34% |
| 2001-12-31 | $1.23 Million | +163.92% |
| 2000-12-31 | $-1.92 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Cutera Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 30142300000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $20.00K | % |
| Other Components | $131.50 Million | % |
| Total Equity | $-171.83 Million | 100.00% |
Cutera Inc Competitors by Market Cap
The table below lists competitors of Cutera Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Betonjaya Manunggal Tbk
JK:BTON
|
$1.70 Million |
|
Fifax Abp
HE:FIFAX
|
$1.70 Million |
|
Tysnes Sparebank
OL:TYSB
|
$1.70 Million |
|
Metronic Global Bhd
KLSE:0043
|
$1.70 Million |
|
Nevada Sunrise Gold Corporation
PINK:NVSGF
|
$1.70 Million |
|
CHARLES RIV LAB INT
BE:RV6
|
$1.70 Million |
|
Enertime SAS
PA:ALENE
|
$1.70 Million |
|
CDN Maverick Capital Corp
OTCQB:AXVEF
|
$1.70 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Cutera Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from -15,181,000 to -171,830,000, a change of -156,649,000.
- Net loss of 162,833,000 reduced equity.
- Share repurchases of 3,297,000 reduced equity.
- Other comprehensive income increased equity by 94,000.
- Other factors increased equity by 9,387,000.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-162.83 Million | -94.76% |
| Share Repurchases | $3.30 Million | -1.92% |
| Other Comprehensive Income | $94.00K | +0.05% |
| Other Changes | $9.39 Million | +5.46% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Cutera Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2000-12-31 | $-0.24 | $0.10 | x |
| 2001-12-31 | $0.14 | $0.10 | x |
| 2002-12-31 | $0.35 | $0.10 | x |
| 2003-12-31 | $0.89 | $0.10 | x |
| 2004-12-31 | $5.60 | $0.10 | x |
| 2005-12-31 | $7.01 | $0.10 | x |
| 2006-12-31 | $7.69 | $0.10 | x |
| 2007-12-31 | $7.69 | $0.10 | x |
| 2008-12-31 | $8.78 | $0.10 | x |
| 2009-12-31 | $7.59 | $0.10 | x |
| 2010-12-31 | $7.05 | $0.10 | x |
| 2011-12-31 | $6.63 | $0.10 | x |
| 2012-12-31 | $6.44 | $0.10 | x |
| 2013-12-31 | $5.84 | $0.10 | x |
| 2014-12-31 | $5.65 | $0.10 | x |
| 2015-12-31 | $3.58 | $0.10 | x |
| 2016-12-31 | $4.44 | $0.10 | x |
| 2017-12-31 | $4.41 | $0.10 | x |
| 2018-12-31 | $3.37 | $0.10 | x |
| 2019-12-31 | $3.26 | $0.10 | x |
| 2020-12-31 | $3.41 | $0.10 | x |
| 2021-12-31 | $3.08 | $0.10 | x |
| 2022-12-31 | $-0.81 | $0.10 | x |
| 2023-12-31 | $-8.64 | $0.10 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Cutera Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -76.67%
- • Asset Turnover: 0.61x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is below the historical average (5.19%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2000 | 0.00% | 10.88% | 1.35x | 0.00x | $1.23 Million |
| 2001 | 190.78% | 12.10% | 1.55x | 10.18x | $2.22 Million |
| 2002 | 21.25% | 2.33% | 1.84x | 4.97x | $349.40K |
| 2003 | 39.44% | 7.95% | 1.62x | 3.07x | $2.32 Million |
| 2004 | 5.49% | 7.14% | 0.65x | 1.18x | $-3.09 Million |
| 2005 | 14.20% | 18.25% | 0.68x | 1.15x | $4.08 Million |
| 2006 | 1.93% | 2.11% | 0.75x | 1.22x | $-8.85 Million |
| 2007 | 9.61% | 10.33% | 0.73x | 1.27x | $-431.30K |
| 2008 | -2.56% | -3.44% | 0.61x | 1.23x | $-14.08 Million |
| 2009 | -17.53% | -32.93% | 0.44x | 1.20x | $-27.76 Million |
| 2010 | -11.02% | -19.74% | 0.48x | 1.17x | $-20.06 Million |
| 2011 | -10.99% | -16.69% | 0.54x | 1.22x | $-19.22 Million |
| 2012 | -7.21% | -8.47% | 0.69x | 1.24x | $-15.63 Million |
| 2013 | -5.63% | -6.36% | 0.69x | 1.29x | $-13.17 Million |
| 2014 | -13.18% | -13.58% | 0.72x | 1.35x | $-18.66 Million |
| 2015 | -8.87% | -4.69% | 1.22x | 1.55x | $-9.44 Million |
| 2016 | 4.22% | 2.18% | 1.29x | 1.51x | $-3.52 Million |
| 2017 | 46.22% | 19.80% | 1.36x | 1.71x | $23.50 Million |
| 2018 | -66.33% | -18.91% | 1.67x | 2.10x | $-35.41 Million |
| 2019 | -26.88% | -6.80% | 1.60x | 2.48x | $-16.94 Million |
| 2020 | -41.98% | -16.17% | 1.11x | 2.33x | $-29.57 Million |
| 2021 | 3.65% | 0.89% | 0.83x | 4.95x | $-3.59 Million |
| 2022 | 0.00% | -32.62% | 0.48x | 0.00x | $-80.82 Million |
| 2023 | 0.00% | -76.67% | 0.61x | 0.00x | $-145.65 Million |
Industry Comparison
This section compares Cutera Inc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Cutera Inc (CUTR) | $-252.87 Million | 0.00% | N/A | $1.70 Million |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |